Comparative Pharmacology
Head-to-head clinical analysis: KLOR CON M10 versus KLOR CON M15.
Peer-Reviewed Evidence
Head-to-head clinical analysis: KLOR CON M10 versus KLOR CON M15.
KLOR-CON M10 vs KLOR-CON M15
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium chloride dissociates to release potassium ions which are essential for maintaining cellular membrane potential, nerve impulse transmission, muscle contraction, and acid-base balance. Replacement of potassium deficits prevents or corrects hypokalemia.
Potassium is the major intracellular cation; it is necessary for conduction of nerve impulses, contraction of cardiac, skeletal, and smooth muscle, maintenance of normal renal function, acid-base balance, and carbohydrate metabolism.
For potassium depletion: 10 mEq orally three to four times daily, with maximum single dose of 20 mEq and total daily dose up to 100 mEq. Dosage must be individualized based on serum potassium levels and clinical response.
Oral: 15 mEq (1 tablet) once daily or as directed; range 15-100 mEq/day divided doses. Maximum 150 mEq/day.
None Documented
None Documented
Not applicable; potassium is an electrolyte with continuous homeostatic regulation. The plasma half-life of potassium is approximately 2-3 hours, but this is not clinically meaningful as elimination is dependent on renal function and total body stores.
Not applicable; potassium is not eliminated by first-order kinetics. Serum potassium decline depends on redistribution and renal function, with a half-life of approximately 1-1.5 hours for acute redistribution but prolonged in renal impairment.
Renal: >90% of potassium intake is excreted by the kidneys, primarily via distal tubular secretion.
Renal: >90% as potassium ions; fecal: <5%; biliary: negligible.
Category C
Category C
Potassium Supplement
Potassium Supplement